FAM122A ensures cell cycle interphase progression and checkpoint control by inhibiting B55α/PP2A through helical motifs
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
FAM122A ensures cell cycle interphase progression and checkpoint control by inhibiting B55α/PP2A through helical motifs ; volume:15 ; number:1 ; day:10 ; month:7 ; year:2024 ; pages:1-20 ; date:12.2024
Nature Communications ; 15, Heft 1 (10.7.2024), 1-20, 12.2024
- Creator
-
Wasserman, Jason S.
Faezov, Bulat
Patel, Kishan R.
Kurimchak, Alison M.
Palacio, Seren M.
Glass, David J.
Fowle, Holly
McEwan, Brennan C.
Xu, Qifang
Zhao, Ziran
Cressey, Lauren
Johnson, Neil
Duncan, James S.
Kettenbach, Arminja N.
Dunbrack, Roland L.
Graña, Xavier
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-50015-7
- URN
-
urn:nbn:de:101:1-2409272101592.950515177920
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wasserman, Jason S.
- Faezov, Bulat
- Patel, Kishan R.
- Kurimchak, Alison M.
- Palacio, Seren M.
- Glass, David J.
- Fowle, Holly
- McEwan, Brennan C.
- Xu, Qifang
- Zhao, Ziran
- Cressey, Lauren
- Johnson, Neil
- Duncan, James S.
- Kettenbach, Arminja N.
- Dunbrack, Roland L.
- Graña, Xavier
- SpringerLink (Online service)
Other Objects (12)
Monalizumab: inhibiting the novel immune checkpoint NKG2A
Cryo-EM structures of PP2A:B55–FAM122A and PP2A:B55–ARPP19
PP2A and tumor radiotherapy
![PRG-1 regulates cell adhesion via PP2A/β1-integrin [PP2A-beta1-integrin] signaling](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
PRG-1 regulates cell adhesion via PP2A/β1-integrin [PP2A-beta1-integrin] signaling
helical
Chemogenetic profiling reveals PP2A‐independent cytotoxicity of proposed PP2A activators iHAP1 and DT‐061
Multifunctional composite interphase
Multifunctional composite interphase
Altering phosphorylation in cancer through PP2A modifiers
Methylation-regulated decommissioning of multimeric PP2A complexes
Crystal structure of a PP2A B56-BubR1 complex and its implications for PP2A substrate recruitment and localization
LASS2 enhances chemosensitivity to cisplatin by inhibiting PP2A-mediated β-catenin dephosphorylation in a subset of stem-like bladder cancer cells
Monalizumab: inhibiting the novel immune checkpoint NKG2A
Cryo-EM structures of PP2A:B55–FAM122A and PP2A:B55–ARPP19
PP2A and tumor radiotherapy
PRG-1 regulates cell adhesion via PP2A/β1-integrin [PP2A-beta1-integrin] signaling
helical
Chemogenetic profiling reveals PP2A‐independent cytotoxicity of proposed PP2A activators iHAP1 and DT‐061
Multifunctional composite interphase
Multifunctional composite interphase
Altering phosphorylation in cancer through PP2A modifiers
Methylation-regulated decommissioning of multimeric PP2A complexes
Crystal structure of a PP2A B56-BubR1 complex and its implications for PP2A substrate recruitment and localization
LASS2 enhances chemosensitivity to cisplatin by inhibiting PP2A-mediated β-catenin dephosphorylation in a subset of stem-like bladder cancer cells
Monalizumab: inhibiting the novel immune checkpoint NKG2A
Cryo-EM structures of PP2A:B55–FAM122A and PP2A:B55–ARPP19
PP2A and tumor radiotherapy
PRG-1 regulates cell adhesion via PP2A/β1-integrin [PP2A-beta1-integrin] signaling
helical
Chemogenetic profiling reveals PP2A‐independent cytotoxicity of proposed PP2A activators iHAP1 and DT‐061
Multifunctional composite interphase
Multifunctional composite interphase
Altering phosphorylation in cancer through PP2A modifiers
Methylation-regulated decommissioning of multimeric PP2A complexes
Crystal structure of a PP2A B56-BubR1 complex and its implications for PP2A substrate recruitment and localization